Atlas Trials

A Study of Abiraterone in Combination With SHR3162 in the Treatment of mCRPC

Clinical trial NCT04108247 · UNKNOWN

Trial details

NCT number
NCT04108247
Sponsor
Jiangsu HengRui Medicine Co., Ltd.
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Prostate Cancer Castration-resistant Prostate Cancer
Start date
2019-09-26
Primary completion
2023-06-01
Enrollment
39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.